<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl5" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th>KHM-3S</th><th>IC<sub>50</sub></th></tr></thead><tbody><tr><td>Erlotinib</td><td>0.5 &#956;M</td></tr><tr><td>Erlotinib + HGF</td><td>&gt;10 &#956;M</td></tr><tr><td>Erlotinib + HGF + Crizotinib</td><td>0.3 &#956;M</td></tr></tbody></table><table-wrap-foot><fn><p>&#8226; HGF induces resistance to Erlotinib.</p></fn><fn><p>&#8226; Crizotinib blocks HGF-induced resistance to Erlotinib, restoring sensitivity.</p></fn></table-wrap-foot></table-wrap>